2023 Vaccines for Adults (VFA)

Closed Solicitation Posted Apr 5, 2023

This opportunity was awarded. See its 7 award notices in the notice history.

Solicitation number: 75D301-23-R-72568
Agency: CDC Office of Acquisition Services Centers for Disease Control and Prevention, Department of Health and Human Services
Responses due: Apr 19, 2023, 5:00 PM ET
Set-aside: No set-aside

Opportunity facts

NAICS code: 325412 Pharmaceutical Preparation Manufacturing
PSC: 6505 Drugs And Biologicals
Place of performance: United States

Notice details come from SAM.gov. Updated Apr 11, 2023.

About this opportunity

Written by GovTribe AI · Jan 1, 2024

This solicitation seeks proposals for indefinite-delivery, indefinite-quantity contracts to supply various adult vaccines to the Centers for Disease Control and Prevention for the period of July 1, 2023 through June 30, 2024. Vaccines required include hepatitis A, hepatitis B, hepatitis A & B combination, pneumococcal polysaccharide, tetanus and diphtheria toxoids, herpes zoster, tetanus, reduced diphtheria toxoid and acellular pertussis, measles, mumps and rubella, meningococcal conjugate, human papillomavirus, varicella, pneumococcal conjugate, and serogroup B meningococcal vaccines. Proposals are due by 5:00 PM EST on April 19, 2023 with inquiries accepted until April 12, 2023.

No set-aside designation was used. The solicitation involves an estimated 1.5 to 3 million doses of 12 different adult vaccines with minimum and maximum order quantities specified. The period of performance is one year from July 1, 2023 through June 30, 2024. The place of performance is within the United States and the vaccines will support adult immunization programs through the CDC and state health departments.

Notice text

2 versions

As posted on SAM.gov.

Update #2 · Latest · Apr 11, 2023

This is an amendment to the original solicitation to update FAR Clause 52.232-40.

The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) requires the award of one or more indefinite-delivery, indefinite-quantity contracts for the purchase of the following adult vaccines, at the estimated quantities listed, manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration.

Hepatitis A adult vaccine:
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 1,000,000 Doses
Minimum: 100 Doses

Hepatitis B adult vaccine:
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 750,000 Doses
Minimum: 100 Doses

Hepatitis A & B combination adult vaccine:
Min. Shelf Life: 12 Months
Fed. Excise Tax: $1.50 per dose
Maximum: 275,000 Doses
Minimum: 100 Doses

Pneumococcal Polysaccharide vaccine:
Min. Shelf Life: 12 Months
Fed. Excise Tax: N/A
Maximum: 500,000 Doses
Minimum: 100 Doses

Tetanus and Diphtheria Toxoids vaccine for adults:
Min. Shelf Life: 12 Months
Fed. Excise Tax: $1.50 per dose
Maximum: 100,000 Doses
Minimum: 100 Doses

Herpes Zoster vaccine for adults:
Min. Shelf Life: 12 Months
Fed. Excise Tax: N/A
Maximum: 500,000 Doses
Minimum: 100 Doses

Tetanus, Reduced Diphtheria Toxoid, and Acellular Pertussis (TDaP) vaccine:
Min. Shelf Life: 12 Months
Fed. Excise Tax: $2.25 per dose
Maximum: 850,000 Doses
Minimum: 100 Doses

Measles, Mumps, and Rubella vaccine:
Min. Shelf Life: 12 Months
Fed. Excise Tax: $2.25 per dose
Maximum: 250,000 Doses
Minimum: 100 Doses

Meningococcal Conjugate (Groups A,C,Y &W) vaccine:
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 200,000 Doses
Minimum: 100 Doses

Human Papillomavirus (HPV9) vaccine:
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 300,000 Doses
Minimum: 100 Doses

Varicella vaccine:
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 150,000 Doses
Minimum: 10 Doses

Pneumococcal Conjugate (PCV) vaccine:
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 500,000 Doses
Minimum: 100 Doses

Serogroup B Meningococcal vaccine:
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 200,000 Doses
Minimum: 100 Doses

All vaccines are required to be delivered within 15 business days after receipt of order. Vaccines shall be shipped F.O.B. destination, as directed by delivery orders. The period of performance shall be July 1, 2023 through June 30, 2024.

The vaccines awarded under these contracts will be purchased for NCIRD's immunization awardees (the fifty state health departments, several large city programs, and current and former U.S. Territories) to support adult immunization programs as provided under Section 317(j) of the Public Health Service Act.

This acquisition is being conducted in accordance with FAR Part 12 and Part 15 procedures. Please find the solicitation attached to this notice.

Offers shall be submitted by 5:00 PM Eastern Standard Time (EST) on April 19, 2023.

Any inquiries regarding this solicitation shall be submitted in writing to Brian Swann at qty0@cdc.gov and Pellumbeshe Hoxhaj at kfx2@cdc.gov no later than April 12, 2023 at 5:00 PM EST. Telephone inquiries will not be honored.

Update #1 · Apr 5, 2023